Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
11%
OVERLAP
BY WEIGHT
49
# OF OVERLAPPING
HOLDINGS
FHLC
342
HOLDINGS
16%
ALSO IN XPH
XPH
60
HOLDINGS
83%
ALSO IN FHLC
SECTOR DRIFT (FHLC minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
BRISTOL-MYERS SQUIBB CO | 1.7% | 1.7% | 1.7% |
|
JOHNSON & JOHNSON | 8.6% | 1.7% | 1.7% |
|
MERCK & CO. INC. | 4.4% | 1.7% | 1.7% |
|
ELI LILLY & CO | 13.9% | 1.6% | 1.6% |
|
PFIZER INC | 2.3% | 1.5% | 1.5% |
FHLC Overweight Relative to XPH
|
ELI LILLY & CO | 12.3% |
|
JOHNSON & JOHNSON | 7.0% |
|
ABBVIE INC | 6.0% |
|
UNITEDHEALTH GROUP INC | 5.7% |
|
AMGEN INC | 2.9% |
|
MERCK & CO. INC. | 2.8% |
|
THERMO FISHER SCIENTIFIC INC | 2.7% |
|
ABBOTT LABORATORIES | 2.4% |
|
GILEAD SCIENCES INC | 2.4% |
|
INTUITIVE SURGICAL INC | 2.3% |
FHLC Underweight Relative to XPH
|
CRINETICS PHARMACEUTICALS INC | -3.7% |
|
MBX BIOSCIENCES INC | -3.0% |
|
DEFINIUM THERAPEUTICS INC | -2.8% |
|
ENLIVEN THERAPEUTICS, INC. | -2.1% |
|
NUVATION BIO INC CLASS A | -2.1% |
|
ALUMIS INC | -2.1% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.1% |
|
TREVI THERAPEUTICS, INC. | -2.0% |
|
LIQUIDIA TECHNOLOGIES, INC. | -1.9% |
|
EDGEWISE THERAPEUTICS, INC. | -1.9% |